Brief: Iveric Bio Completes Patient Enrollment Of GATHER2 Clinical Trial Of Zimura Before Schedule
26/07/2021 12:41
July 26 (Reuters) - Iveric Bio Inc ISEE.O :
* IVERIC BIO COMPLETES PATIENT ENROLLMENT OF GATHER2 PIVOTAL
CLINICAL TRIAL OF ZIMURA® AHEAD OF SCHEDULE
Source text for Eikon: ID:nBw2cQ509a
Further company coverage: ISEE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini